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Introduction
• Methicillin-resistant S. pseudintermedius (MRSP) are of 
increasing concern due to its recent spread amongst dog 
populations worldwide (Perreten et al., 2010).
• Limited treatment options are available for MRSP, thus 
alternative treatment is required to combat these  
multidrug-resistant microorganisms in the future.
• Peptoids are oligomers of N-substituted glycines  and 
may mimic biologically active peptides by showing 
antimicrobial properties.
• Peptoids resemble peptides except that the side chains 
are appended to the nitrogen atom of the backbone rather 
than to the α-carbons. They are also characterised by 
being more stable in vitro towards heat, salt, pH 
fluctuations and organic solvents compared to peptides. in 
vivo, peptoids are stable to proteolysis whereas peptides 
are rapidly degraded.
Objective
• To assess the in vitro efficacy of two newly developed peptoids against MRSP and methicillin-susceptible S. 
pseudintermedius isolates of canine origin
Materials and Methods
• Prior to the study, 10 newly developed peptoids were tested for their in vitro efficacy and hemolysis against 
various bacterial species. A lysine peptoid hybrid (B1) and a pure peptoid (D2) showing both a low minimum 
inhibitory concentration (MIC) and a low rate of hemolysis against S. pseudintermedius were selected for this 
study.
• B1 and D2 were tested for their in vitro activity against 50 clinical S. pseudintermedius isolates of canine 
origin using the broth microdilution method (CLSI, 2008). Ten of these isolates were MRSP and 40 isolates 
were MSSP, and all isolates had been collected at our diagnostic lab between 2007 and 2010. 
• B1 and B2 were also tested in a time kill kinetic study against one representative S. pseudintermedius isolate. 
Survival of a standard inoculum (5*105) of this isolate was observed over time after inoculation without peptoid, 
at 1*MIC and at 4*MIC.
Results
MIC determinations (Fig .1)
• Low MIC’s ranging from 1.56-6.25 µM were observed for B1 and D2. MICs did not differ 
between MSSP and MRSP.
• MICs were normally distributed → no obvious evidence of resistance in the 50 isolates 
tested.
Time kill kinetics (Fig 2a and 2b)
• Both B1 and D2 had a concentration-dependant antimicrobial effect on S. 
pseudintermedius.
• B1 acted more rapidly with complete killing at 4 * MIC in 30 min.
• D2 was slightly slower taking 2 hours to kill at 4 * MIC.
Conclusions
• Two novel peptoid compounds were shown to have a rapid concentration-dependant effect
against S. pseudintermedius of canine origin, irrespective of antibiotic resistance phenotypes.
• The rapid killing resembles the pharmacodynamics of antiseptics but the mechanism of 
action is unknown.
• The next step will be to test the effect and toxicity of topical formulations of the two 
compounds in vivo, for example in a mice skin infection model.
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